Posted inBiotechnology
Adding Dermal Absorption to Toxicokinetic Modeling
In the ever-evolving landscape of toxicology and exposure science, comprehending the pathways through which chemicals enter the human body remains…
Posted inBiotechnology
Rebranded Belgian biotech lands $125M for rescued Galapagos drug candidates
After launching in 2025 as a refuge for shipwrecked assets from Galapagos, Onco3R Therapeutics is rebranding as Coultreon Biopharma and…
Posted inBiotechnology
Cheese3D Tracks Whole-Face Movement in Mice
In the realm of neuroscience, the precise measurement and analysis of animal behavior is essential for unraveling the neural mechanisms…
Posted inBiotechnology
Geometry-Aware Framework Advances Whole-Brain Dynamics Mapping
In an unprecedented advance for the field of neuroimaging, researchers have unveiled a breakthrough methodology that promises to revolutionize non-invasive…
Posted inBiotechnology
Family Carers’ Compassion: A Systematic Review
In the evolving landscape of geriatric care, the role of family carers remains both crucial and complex, often balancing emotional…
Posted inBiotechnology
Seaport, Hemab chart courses for $180M IPOs to fund depression, clotting candidates
Both Seaport Therapeutics and Hemab Therapeutics are hoping to bring in around $180 million each from their public listings this…
Posted inBiotechnology
Compass Therapeutics’ stock heads south after cancer bispecific misses on overall survival
Compass Therapeutics shed half its stock price this morning as investors digested its bispecific antibody’s failure to hit an overall…
Posted inBiotechnology
Amplified 1525 nm Luminescence via Dye-Sensitized Energy Transfer
In a groundbreaking development poised to revolutionize optical materials and photonic technologies, a team of researchers has unveiled an innovative…
Posted inBiotechnology
Astellas thins early pipeline, swaps out struggling rare disease gene therapy
Astellas Pharma has done some spring cleaning of its pipeline, dropping two phase 1 candidates and slamming the brakes on…
Posted inBiotechnology
Existing Drugs Could Enhance Treatment Options for Infant Leukemia
A groundbreaking preclinical study has unveiled the potential of repurposing three clinically available drugs to target one of the most…